Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
Xuning Wang,1,2,* Shixiang Wang,3,* Yalin Han,1,4 Maolin Xu,1 Peng Li,1 Mu Ke,1 Zhipeng Teng,1 Pu Huang,1 Ziyan Diao,2,5 Yongfeng Yan,1 Qingyu Meng,1 Yanshen Kuang,1 Wei Zheng,1 Hongyi Liu,1 Xuesong Liu,3 Baoqing Jia1 1The Air Force Hospital of Northern Theater PLA, Shenyang, People’...
Guardado en:
Autores principales: | Wang X, Wang S, Han Y, Xu M, Li P, Ke M, Teng Z, Huang P, Diao Z, Yan Y, Meng Q, Kuang Y, Zheng W, Liu H, Liu X, Jia B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1af56eeb7b534e208fa176bad5a045fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
<i>CSMD1</i> Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Taobi Huang, et al.
Publicado: (2021) -
CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu N, et al.
Publicado: (2021) -
CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer
por: Fan X, et al.
Publicado: (2021) -
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
por: Hye Ryeon Kim, et al.
Publicado: (2021) -
Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021)